ECP 2026: Combined Approach Predicts Metastasis in Prostate Cancer - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

ECP 2026: Combined Approach Predicts Metastasis in Prostate Cancer

  • September 17, 2026

  • 3 min

Share

Objective:

To investigate whether molecular information from primary tumor regions can identify prostate cancer likely to spread, potentially reducing unnecessary lymph node testing.

Approach:
  • Study Design: Analyzed tissue from 51 prostate cancer patients using spatial transcriptomics to assess gene activity in primary tumor regions and matched lymph node metastases.
  • Machine Learning: Trained machine learning models on molecular profiles to recognize patterns linked to lymph node involvement.
Key Findings:
  • Primary tumor regions associated with lymph node metastases exhibited a distinct molecular profile.
  • Machine learning models demonstrated promising performance in identifying patients at higher risk of lymph node metastasis.
Limitations:
  • The work is exploratory and requires further validation before clinical application.
  • The study does not yet incorporate morphology-based machine learning approaches.
Sources:

Original Source(s)

Related Content